Sol-Gel Technologies Ltd. (SLGL) stock
SLGLNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 19, 2026Score 10/30
$55.12−1.13 (-2.01%)
Close on Nov 13, 2026Market cap $153.57MP/E –Yield –
Sol-Gel Technologies ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
For fiscal 2025 it was -$7.43M. The highest annual figure on record is $3.84M in fiscal 2021.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$7.43M | – |
| FY2024 | Dec 31, 2024 | -$11.78M | – |
| FY2023 | Dec 31, 2023 | -$28.96M | – |
| FY2022 | Dec 31, 2022 | -$15.68M | -508.0% |
| FY2021 | Dec 31, 2021 | $3.84M | – |
| FY2020 | Dec 31, 2020 | -$29.29M | – |
| FY2019 | Dec 31, 2019 | -$25.06M | – |
| FY2018 | Dec 31, 2018 | -$32.76M | – |
| FY2017 | Dec 31, 2017 | -$31.16M | – |
| FY2016 | Dec 31, 2016 | -$20.40M | – |
| FY2015 | Dec 31, 2015 | -$9.35M | – |
See a number that looks wrong?